MSNZ-Standorte (in alphabetischer Reihenfolge)
Inhaltsverzeichnis
- Mildred Scheel School of Oncology (MSSO) am Zentrum für Integrierte Onkologie (CIO) Aachen Bonn Köln Düsseldorf
- Mildred-Scheel-Nachwuchszentrum Dresden
- Mildred-Scheel-Nachwuchszentrum Frankfurt-Marburg
- Mildred-Scheel-Nachwuchszentrum am Universitären Cancer Center Hamburg (UCCH)
- Mildred-Scheel-Nachwuchszentrum Würzburg
Die Mildred-Scheel-Nachwuchszentren (MSNZ) werden von der Deutschen Krebshilfe gefördert. Ziel dieser fünf Zentren ist es, junge Forscher:innen aus den Lebens- und Medizinwissenschaften bestmöglich zu unterstützen, damit sie unabhängige Forschung im Bereich der molekularen Onkologie betreiben können.
Im Folgenden stellen wir die fünf Standorte vor.
Mildred Scheel School of Oncology (MSSO) am Zentrum für Integrierte Onkologie (CIO) Aachen Bonn Köln Düsseldorf
The Mildred Scheel School of Oncology Aachen-Bonn-Cologne-Düsseldorf (MSSO ABCD) brings together four leading research centers in the ABCD region: the University Hospitals of Aachen, Bonn, Cologne and Düsseldorf as well as the Faculties of Mathematics and Natural Sciences of the Universities Universities of Aachen, Bonn, Cologne and Düsseldorf. Together, these four partner sites form a unique and internationally recognized research network dedicated to translational oncology. The region combines outstanding expertise in cancer genomics, tumor immunology, and precision oncology, supported by close collaboration between leading clinicians and internationally competitive cancer researchers. The MSSO ABCD offers an interdisciplinary environment where Physician Scientists and Medical Scientists can work at the interface of basic research and clinical application. Access to cutting-edge technologies – particularly next-generation sequencing, high-performance computational biology, high-throughput screening and in vivo imaging – enables innovative research approaches and fosters the development of tomorrow’s cancer therapies. Website MSNZ Bonn-Köln-Düsseldorf
Sprecher
Prof. Dr. med. Dr. nat. med. Roland Ullrich
Department I for Internal Medicine, University Hospital of Cologne
E-Mail:
Telefon: +49 221 478 89771
Stellv. Sprecher
Prof. Dr. med. Michael Hölzel
Experimental Oncology, University Hospital Bonn
Koordination
Dr. rer. nat. Stefanie Habersetzer
Department I for Internal Medicine, University Hospital of Cologne
E-Mail:
Telefon: +49 221 478-15154
Mildred-Scheel-Nachwuchszentrum Dresden
The Mildred Scheel Early Career Center Dresden (MSNZ Dresden) fosters the next generation of clinician and medical scientists in precision oncology through its P² – Personalized Career Development in Precision Oncology program. P² provides tailored and flexible career paths that enable clinician scientists to combine clinical training with protected research time and support medical scientists in developing scientific independence and establishing their own research profiles. By bringing clinical and basic science expertise together – including through interdisciplinary tandem structures – the program creates an environment in which innovative research can be translated more effectively from bench to bedside. Its overarching goal is to empower early-career scientists to pursue independent careers while advancing translational research and precision oncology for the benefit of patients. To address individual needs at different career stages, P² provides tailored support ranging from medical doctoral and clinical fellowships to protected research opportunities and interdisciplinary tandems.
Sprecher
Prof. Dr. Martin Bornhäuser
Universitäts KrebsCentrum / MK1
E-Mail:
Telefon: +49 351 458 4704
Prof. Dr. Frank Buchholz
Universitäts KrebsCentrum – Medical Systems Biology
E-Mail:
Telefon: +49 351 463 40277
Koordination
Anja Glenk
Dresden School of Clincial Science (DSCS)
E-Mail:
Telefon: +49 351 458 15548
Mandy Erlitz
Universitäts KrebsCentrum – MSB
E-Mail:
Telefon: +49 351 463 40277
Mildred-Scheel-Nachwuchszentrum Frankfurt-Marburg
The Mildred Scheel Career Center (MSNZ) Frankfurt-Marburg supports the next generation of scientists in cancer research by systematically promoting young physicians conducting research (clinician scientists, CS) and non-clinical researchers in oncology (medical scientists, MS). Its main goals are (1) to establish internationally competitive, continuous career paths for CS and MS, covering all career levels, (2) to create attractive positions for scientific target roles (e.g. professorships and group leader positions), (3) to encourage and support international mobility (e.g. through Short Term Fellowships), (4) to promote equal opportunities and (5) to support individual career development through qualification and mentoring programs available at both partner sites. The scientific program of the MSNZ is closely linked to the joint research program of the University Cancer Center (UCT) Frankfurt-Marburg, the German Cancer Consortium (DKTK) and the Frankfurt Cancer Institute (FCI). Website MSNZ Frankfurt-Marburg
Sprecher
Prof. Dr. med. Christian Brandts
Director University Cancer Center (UCT) Frankfurt, Universitätsmedizin Frankfurt
E-Mail:
Telefon: +49 69 6301-87334
Stellv. Sprecherin
Prof. Dr. rer. nat. Katharina Imkeller
Edinger Institute, Universitätsmedizin Frankfurt
E-Mail:
Kontakt Marburg
Prof. Dr. med. Thomas Wündisch
Director Comprehensive Cancer Center (CCC) Marburg, University Hospital Marburg
E-Mail:
Telefon: +49 6421 58-64761
Koordination
Dr. Tinka Haydn
University Cancer Center (UCT) Frankfurt-Marburg
E-Mail: |
Telefon: +49 69 6301-7251
Mildred-Scheel-Nachwuchszentrum am Universitären Cancer Center Hamburg (UCCH)
The Mildred Scheel Cancer Career Center Hamburg (MSNZ Hamburg) supports clinician and medical scientists at all career stages through funding, mentoring, networking and career development. Embedded within the University Cancer Center Hamburg (UCC Hamburg) at the University Medical Center Hamburg-Eppendorf (UKE), the center promotes interdisciplinary cancer research with a particular focus on dissemination and metastasis. MSNZ Hamburg fosters scientific excellence, collaboration and empowers the next generation of oncology researchers. A special focus is aimed at collaborative initiatives bridging different institutions and departments within the UCC Hamburg but also with external partner institutions in the region. Website MSNZ Hamburg
Sprecher MSNZ Executive Board
Prof. Dr. med. Carsten Bokemeyer
E-Mail:
Stellv. Sprecher
Prof. Dr. rer. nat. Kai Rothkamm
E-Mail:
Leitung MSNZ Office
Dr. rer. nat. Inga Melzer
E-Mail: |
Mildred-Scheel-Nachwuchszentrum Würzburg
The Mildred Scheel Early Career Center Würzburg (MSNZ Würzburg) supports young researchers from the life and medical sciences in developing independent careers in molecular oncology. As a joint center of the University of Würzburg and the University Hospital Würzburg, located close to CCC Mainfranken and the Max Planck Research Group Systems Immunology, it connects basic, translational and clinical cancer research. The scientific program addresses mechanisms of tumor initiation, development and maintenance, with a focus on transcriptional deregulation, disrupted protein homeostasis, tumor–immune interactions, AI-driven oncology and CAR-T cell therapy. MSNZ Würzburg currently supports Postdoc Projects and Joint Projects to advance innovative translational and therapeutic approaches. Website MSNZ Würzburg
Sprecher
Prof. Dr. Martin Eilers
Department of Bioechemistry and Molecular Biology, Julius-Maximilians-University Würzburg
E-Mail:
Telefon: +49 931 31-8411
Koordination
Dr. Martin Czolbe
MSNZ/NCT WERA
E-Mail:
Telefon: +49 931 201-35309